Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2011
  • Online publication date: April 2011

17 - Clinical and biological features of acute disseminated encephalomyelitis

from Section 4 - ADEM

Summary

Plasma exchange involves non-selectively removing plasma components that are potentially pathogenic in immune-mediated diseases from a patient's blood. Intravenous immunoglobulin used for therapeutic purposes are pooled human immunoglobulins derived from the plasma of 10000-100000 healthy donors. The major component of intravenous immunoglobulins (IVIg) preparations is IgG; very small amounts of other immunoglobulins, immunoglobulin fragments, and other smaller plasma proteins are also present. IVIg affect several components of the immune system and have been used successfully in the treatment of several neuroimmunological disorders. IVIg therapy has been evaluated both as a treatment of acute demyelinating relapses as well as a maintenance therapy to alter the disease course in adult patients with multiple sclerosis (MS). This chapter focuses on studies pertaining to the treatment of acute relapses. Plasma exchange might be an effective and relatively well-tolerated treatment option for severe demyelinating relapses in MS patients.

References

1. JohnsonRT. The pathogenesis of acute viral encephalitis and postinfectious encephalomyelitis. J Infect Dis 1987;155:359–364.
2. ScottTF. Postinfectious and vaccinal encephalitis. Med Clin North Am 1967;51:701–717.
3. SoodSC, SinghH. Acute disseminated encephalo-myelitis complicating smallpox. Indian Pediatr 1967;4:361–363.
4. BehanPO, MooreMJ, LisakRP. Acute disseminated encephalomyelitis. Br J Clin Pract 1974;28:243–245.
5. AlvordEC. Acute disseminated encephalomyelitis and “allergic” neuroencephalopathies: Multiple sclerosis and other demyelinating diseases. In Handbook of Clinical Neurology, ed. PJ Vinken and GW Bruyn. Amsterdam: North Holland Publishing Company; 1970:500–571.
6. KruppLB, BanwellB, TenembaumS. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007;68:S7–12.
7. LeakeJA, AlbaniS, KaoAS, et al. Acute disseminated encephalomyelitis in childhood: Epidemiologic, clinical and laboratory features. Pediatr Infect Dis J 2004;23:756–764.
8. TorisuH, KiraR, IshizakiY, et al. Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan. Brain Dev 2010;32:454–462. Epub 2009/11/28.
9. PohlD, HennemuthI, von KriesR, HanefeldF. Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: Results of a nationwide survey. Eur J Pediatr 2007;166:405–412.
10. BanwellB, KennedyJ, SadovnickD, et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology 2009;72:232–239.
11. HynsonJL, KornbergAJ, ColemanLT, ShieldL, HarveyAS, KeanMJ. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001;56:1308–1312.
12. DaleRC, de SousaC, ChongWK, CoxTC, HardingB, NevilleBG. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000;123:2407–2422.
13. AnlarB, BasaranC, KoseG, et al. Acute disseminated encephalomyelitis in children: Outcome and prognosis. Neuropediatrics 2003;34:194–199.
14. TenembaumS, ChamolesN, FejermanN. Acute disseminated encephalomyelitis: A long-term follow-up study of 84 pediatric patients. Neurology 2002;59:1224–1231.
15. MurthyJM. Acute disseminated encephalomyelitis. Neurol India 2002;50:238–243.
16. SinghiPD, RayM, SinghiS, Kumar KhandelwalN. Acute disseminated encephalomyelitis in North Indian children: Clinical profile and follow-up. J Child Neurol 2006;21:851–857.
17. MikaeloffY, CaridadeG, HussonB, SuissaS, TardieuM. Acute disseminated encephalomyelitis cohort study: Prognostic factors for relapse. Eur J Paediatr Neurol 2007;11:90–95.
18. MikaeloffY, SuissaS, ValleeL, et al. First episode of acute CNS inflammatory demyelination in childhood: Prognostic factors for multiple sclerosis and disability. J Pediatr 2004;144:246–252.
19. MurthyJM, YangalaR, MeenaAK, Jaganmohan ReddyJ. Acute disseminated encephalomyelitis: Clinical and MRI study from South India. J Neurol Sci 1999;165:133–138.
20. GovenderR, WieselthalerNA, NdondoA, WilmshurstJM. Acquired demyelinating disorders of childhood in the Western Cape, South Africa. J Child Neurol 2010;25:48–56.
21. MurthySN, FadenHS, CohenME, BakshiR. Acute disseminated encephalomyelitis in children. Pediatrics 2002;110:e21.
22. GibbonsJL, MillerHG, StantonJB. Para-infectious encephalomyelitis and related syndromes; a critical review of the neurological complications of certain specific fevers. Q J Med 1956;25:427–505.
23. JohnsonR, MilbournPE. Central nervous system manifestations of chickenpox. Can Med Assoc J 1970;102:831–834.
24. NoorbakhshF, JohnsonRT, EmeryD, PowerC. Acute disseminated encephalomyelitis: Clinical and pathogenesis features. Neurol Clin 2008;26:759–780, ix.
25. RiedelK, KempfVA, BechtoldA, KlimmerM. Acute disseminated encephalomyelitis (ADEM) due to Mycoplasma pneumoniae infection in an adolescent. Infection 2001;29:240–242.
26. SamileN, HassanT. Acute disseminated encephalomyelitis in children. A descriptive study in Tehran, Iran. Saudi Med J 2007;28:396–399.
27. BelmanAL, CoylePK, RoqueC, CantosE. MRI findings in children infected by Borrelia burgdorferi. Pediatr Neurol 1992;8:428–431.
28. Alonso-ValleH, MunozR, HernandezJL, MatorrasP. Acute disseminated encephalomyelitis following Leptospira infection. Eur Neurol 2001;46:104–105.
29. DaleRC, ChurchAJ, CardosoF, et al. Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Ann Neurol 2001;50:588–595.
30. OhtakiE, MurakamiY, KomoriH, YamashitaY, MatsuishiT. Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination. Pediatr Neurol 1992;8:137–139.
31. CusmaiR, BertiniE, Di CapuaM, et al. Bilateral, reversible, selective thalamic involvement demonstrated by brain MR and acute severe neurological dysfunction with favorable outcome. Neuropediatrics 1994;25:44–47.
32. MizuguchiM, AbeJ, MikkaichiK, et al. Acute necrotising encephalopathy of childhood: A new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatry 1995;58:555–561.
33. RuggieriM, PolizziA, PavoneL, MusumeciS. Thalamic syndrome in children with measles infection and selective, reversible thalamic involvement. Pediatrics 1998;101:112–119.
34. HartfieldDS, LoewyJA, YagerJY. Transient thalamic changes on MRI in a child with hypernatremia. Pediatr Neurol 1999;20:60–62.
35. MengeT, HemmerB, NesslerS, et al. Acute disseminated encephalomyelitis: An update. Arch Neurol 2005;62:1673–1680.
36. AnSF, GrovesM, MartinianL, KuoLT, ScaravilliF. Detection of infectious agents in brain of patients with acute hemorrhagic leukoencephalitis. J Neurovirol 2002;8:439–446.
37. LannMA, LovellMA, Kleinschmidt-DeMastersBK. Acute hemorrhagic leukoencephalitis: A critical entity for forensic pathologists to recognize. Am J Forensic Med Pathol 2010;31:7–11.
38. HuynhW, CordatoDJ, KehdiE, MastersLT, DedousisC. Post-vaccination encephalomyelitis: Literature review and illustrative case. J Clin Neurosci 2008;15:1315–1322.
39. FenichelGM. Neurological complications of immunization. Ann Neurol 1982;12:119–128.
40. NalinDR. Mumps, measles, and rubella vaccination and encephalitis. BMJ 1989;299:1219.
41. HemachudhaT, PhanuphakP, JohnsonRT, GriffinDE, RatanavongsiriJ, SiriprasomsupW. Neurologic complications of Semple-type rabies vaccine: Clinical and immunologic studies. Neurology 1987;37:550–556.
42. PlesnerAM, Arlien-SoborgP, HerningM. Neurological complications to vaccination against Japanese encephalitis. Eur J Neurol 1998;5:479–485.
43. ShibazakiK, MurakamiT, KushidaR, KurokawaK, TeradaK, SunadaY. Acute disseminated encephalomyelitis associated with oral polio vaccine. Intern Med 2006;45:1143–1146.
44. HorowitzMB, ComeyC, HirschW, MarionD, GriffithB, MartinezJ. Acute disseminated encephalomyelitis (ADEM) or ADEM-like inflammatory changes in a heart-lung transplant recipient: A case report. Neuroradiology 1995;37:434–437.
45. Aboagye-KumiM, YangoA Jr, FischerS, et al. Acute disseminated encephalomyelitis in a renal transplant recipient: A case report. Transplant Proc 2008;40:1751–1753.
46. ReA, GiachettiR. Acute disseminated encephalomyelitis (ADEM) after autologous peripheral blood stem cell transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant 1999;24:1351–1354.
47. AuWY, LieAK, CheungRT, et al. Acute disseminated encephalomyelitis after para-influenza infection post bone marrow transplantation. Leuk Lymphoma 2002;43:455–457.
48. TomonariA, TojoA, AdachiD, et al. Acute disseminated encephalomyelitis (ADEM) after allogeneic bone marrow transplantation for acute myeloid leukemia. Ann Hematol 2003;82:37–40.
49. WoodardP, HeltonK, McDanielH, et al. Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis. Bone Marrow Transplant 2004;33:1151–1157.
50. YehEA, CollinsA, CohenME, DuffnerPK, FadenH. Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics 2004;113:e73–76.
51. DavidP, BaleriauxD, BankWO, et al. MRI of acute disseminated encephalomyelitis after coxsackie B infection. J Neuroradiol 1993;20:258–265.
52. YamamotoY, TakasakiT, YamadaK, et al. Acute disseminated encephalomyelitis following dengue fever. J Infect Chemother 2002;8:175–177.
53. FujimotoH, AsaokaK, ImaizumiT, AyabeM, ShojiH, KajiM. Epstein–Barr virus infections of the central nervous system. Intern Med 2003;42:33–40.
54. TanH, KilicaslanB, OnbasO, BuyukavciM. Acute disseminated encephalomyelitis following hepatitis A virus infection. Pediatr Neurol 2004;30:207–209.
55. SacconiS, SalviatiL, MerelliE. Acute disseminated encephalomyelitis associated with hepatitis C virus infection. Arch Neurol 2001;58:1679–1681.
56. KajiM, KusuharaT, AyabeM, HinoH, ShojiH, NagaoT. Survey of herpes simplex virus infections of the central nervous system, including acute disseminated encephalomyelitis, in the Kyushu and Okinawa regions of Japan. Mult Scler 1996;2:83–87.
57. SilverB, McAvoyK, MikesellS, SmithTW. Fulminating encephalopathy with perivenular demyelination and vacuolar myelopathy as the initial presentation of human immunodeficiency virus infection. Arch Neurol 1997;54:647–650.
58. KameiA, IchinoheS, OnumaR, HiragaS, FujiwaraT. Acute disseminated demyelination due to primary human herpesvirus-6 infection. Eur J Pediatr 1997;156:709–712.
59. SonmezFM, OdemisE, AhmetogluA, AyvazA. Brainstem encephalitis and acute disseminated encephalomyelitis following mumps. Pediatr Neurol 2004;30:132–134.
60. VoudrisKA, VagiakouEA, SkardoutsouA. Acute disseminated encephalomyelitis associated with parainfluenza virus infection of childhood. Brain Dev 2002;24:112–114.
61. MillerDH, KayR, SchonF, McDonaldWI, HaasLF, HughesRA. Optic neuritis following chickenpox in adults. J Neurol 1986;233:182–184.
62. van AssenS, BosmaF, StaalsLM, et al. Acute disseminated encephalomyelitis associated with Borrelia burgdorferi. J Neurol 2004;251:626–629.
63. HeickA, SkriverE. Chlamydia pneumoniae-associated ADEM. Eur J Neurol 2000;7:435–438.
64. SpiekerS, PetersenD, RolfsA, et al. Acute disseminated encephalomyelitis following Pontiac fever. Eur Neurol 1998;40:169–172.
65. WeiTY, BaumannRJ. Acute disseminated encephalomyelitis after Rocky Mountain spotted fever. Pediatr Neurol 1999;21:503–505.
66. KoibuchiT, NakamuraT, MiuraT, et al. Acute disseminated encephalomyelitis following Plasmodium vivax malaria. J Infect Chemother 2003;9:254–256.
67. OzawaH, NomaS, YoshidaY, SekineH, HashimotoT. Acute disseminated encephalomyelitis associated with poliomyelitis vaccine. Pediatr Neurol 2000;23:177–179.
68. HemachudhaT, GriffinDE, GiffelsJJ, JohnsonRT, MoserAB, PhanuphakP. Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N Engl J Med 1987;316:369–374.
69. BolukbasiO, OzmenogluM. Acute disseminated encephalomyelitis associated with tetanus vaccination. Eur Neurol 1999;41:231–232.
70. SchattenfrohC. Acute disseminated encephalomyelitis after active immunization against early summer encephalitis. Nervenarzt 2004;75:776–779.
71. TenembaumS, ChitnisT, NessJ, HahnJS. Acute disseminated encephalomyelitis. Neurology 2007;68:S23–36.
72. WingerchukDM. The clinical course of acute disseminated encephalomyelitis. Neurol Res 2006;28:341–347.
73. MarchioniE, RavagliaS, PiccoloG, et al. Postinfectious inflammatory disorders: Subgroups based on prospective follow-up. Neurology 2005;65:1057–1065.
74. MaderI, WolffM, NiemannG, KukerW. Acute haemorrhagic encephalomyelitis (AHEM): MRI findings. Neuropediatrics 2004;35:143–146.
75. KuperanS, OstrowP, LandiMK, BakshiR. Acute hemorrhagic leukoencephalitis vs ADEM: FLAIR MRI and neuropathology findings. Neurology 2003;60:721–722.
76. RosmanNP, GottliebSM, BernsteinCA. Acute hemorrhagic leukoencephalitis: Recovery and reversal of magnetic resonance imaging findings in a child. J Child Neurol 1997;12:448–454.
77. KleinCJ, WijdicksEF, EarnestFT. Full recovery after acute hemorrhagic leukoencephalitis (Hurst's disease). J Neurol 2000;247:977–979.
78. RyanLJ, BowmanR, ZantekND, et al. Use of therapeutic plasma exchange in the management of acute hemorrhagic leukoencephalitis: A case report and review of the literature. Transfusion 2007;47:981–986.
79. PayneET, RutkaJT, HoTK, HallidayWC, BanwellBL. Treatment leading to dramatic recovery in acute hemorrhagic leukoencephalitis. J Child Neurol 2007;22:109–113.
80. PoserCM, GoutieresF, CarpentierMA, AicardiJ. Schilder's myelinoclastic diffuse sclerosis. Pediatrics 1986;77:107–112.
81. KepesJJ. Large focal tumor-like demyelinating lesions of the brain: Intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 1993;33:18–27.
82. AlehanF, ErolI, AgildereAM, et al. Posterior leukoencephalopathy syndrome in children and adolescents. J Child Neurol 2007;22:406–413.
83. GoutièresF, AicardiJ. Acute neurological dysfunction associated with destructive lesions of the basal ganglia in children. Ann Neurol 1982;12:328–332.
84. GreenC, RileyDE. Treatment of dystonia in striatal necrosis caused by Mycoplasma pneumoniae. Pediatr Neurol 2002;26:318–320.
85. HiragaA, KuwabaraS, HayakawaS, et al. Voltage-gated potassium channel antibody-associated encephalitis with basal ganglia lesions. Neurology 2006;66:1780–1781.
86. BenselerS, SchneiderR. Central nervous system vasculitis in children. Curr Opin Rheumatol 2004;16:43–50.
87. LanthierS, LortieA, MichaudJ, LaxerR, JayV, deVeberG. Isolated angiitis of the CNS in children. Neurology 2001;56:837–842.
88. CikesN. Central nervous system involvement in systemic connective tissue diseases. Clin Neurol Neurosurg 2006;108:311–317.
89. BanwellB, TenembaumS, LennonVA, et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 2008;70:344–352.
90. PittockSJ, LennonVA, KreckeK, WingerchukDM, LucchinettiCF, WeinshenkerBG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006;63:390–396.
91. IdrissovaZR, BoldyrevaMN, DekonenkoEP, et al. Acute disseminated encephalomyelitis in children: Clinical features and HLA-DR linkage. Eur J Neurol 2003;10:537–546.
92. KimuraS, NezuA, OhtsukiN, KobayashiT, OsakaH, UeharaS. Serial magnetic resonance imaging in children with postinfectious encephalitis. Brain Dev 1996;18:461–465.
93. JacobsRK, AndersonVA, NealeJL, ShieldLK, KornbergAJ. Neuropsychological outcome after acute disseminated encephalomyelitis: Impact of age at illness onset. Pediatr Neurol 2004;31:191–197.
94. McDonaldWI, CompstonA, EdanG, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121–127.
95. BrassSD, CaramanosZ, SantosC, DilengeME, LapierreY, RosenblattB. Multiple sclerosis vs acute disseminated encephalomyelitis in childhood. Pediatr Neurol 2003;29:227–231.
96. OrrellRW. Grand rounds – Hammersmith Hospitals. Distinguishing acute disseminated encephalomyelitis from multiple sclerosis. BMJ 1996;313:802–804.
97. MorimatsuM. Recurrent ADEM or MS? Intern Med 2004;43:647–648.
98. DaleRC, PillaiSC. Early relapse risk after a first CNS inflammatory demyelination episode: Examining international consensus definitions. Dev Med Child Neurol 2007;49:887–893.
99. AlperG, HeymanR, WangL. Multiple sclerosis and acute disseminated encephalomyelitis diagnosed in children after long-term follow-up: Comparison of presenting features. Dev Med Child Neurol 2009;51:480–486.
100. HartMN, EarleKM. Haemorrhagic and perivenous encephalitis: A clinical–pathological review of 38 cases. J Neurol Neurosurg Psychiatry 1975;38:585–591.
101. LoveS. Demyelinating diseases. J Clin Pathol 2006;59:1151–1159.
102. GhoshN, DeLucaGC, EsiriMM. Evidence of axonal damage in human acute demyelinating diseases. J Neurol Sci 2004;222:29–34.
103. WingerchukDM, LucchinettiCF. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol 2007;20:343–350.
104. MengeT, KieseierBC, NesslerS, HemmerB, HartungHP, StuveO. Acute disseminated encephalomyelitis: An acute hit against the brain. Curr Opin Neurol 2007;20:247–254.
105. WucherpfennigKW, StromingerJL. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995;80:695–705.
106. Tejada-SimonMV, ZangYC, HongJ, RiveraVM, ZhangJZ. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 2003;53:189–197.
107. TalbotPJ, PaquetteJS, CiurliC, AntelJP, OuelletF. Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann Neurol 1996;39:233–240.
108. Markovic-PleseS, HemmerB, ZhaoY, SimonR, PinillaC, MartinR. High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: Implications for the initiation of autoimmune response in multiple sclerosis. J Neuroimmunol 2005;169:31–38.
109. LangHL, JacobsenH, IkemizuS, et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 2002;3:940–943.
110. OlsonJK, CroxfordJL, MillerSD. Virus-induced autoimmunity: Potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunol 2001;14:227–250.
111. MokhtarianF, ZhangZ, ShiY, GonzalesE, SobelRA. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice. J Neuroimmunol 1999;95:43–54.
112. Pohl-KoppeA, BurchettSK, ThieleEA, HaflerDA. Myelin basic protein reactive Th2 T cells are found in acute disseminated encephalomyelitis. J Neuroimmunol 1998;91:19–27.
113. JorensPG, VanderBorghtA, CeulemansB, et al. Encephalomyelitis-associated antimyelin autoreactivity induced by streptococcal exotoxins. Neurology 2000;54:1433–1441.
114. FullerKG, OlsonJK, HowardLM, CroxfordJL, MillerSD. Mouse models of multiple sclerosis: Experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease. Methods Mol Med 2004;102:339–361.
115. ClatchRJ, LiptonHL, MillerSD. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: Correlation with clinical signs. J Immunol 1986;136:920–927.
116. RodriguezM, PavelkoKD, NjengaMK, LoganWC, WettsteinPJ. The balance between persistent virus infection and immune cells determines demyelination. J Immunol 1996;157:5699–5709.
117. UbolS, HemachudhaT, WhitakerJN, GriffinDE. Antibody to peptides of human myelin basic protein in post-rabies vaccine encephalomyelitis sera. J Neuroimmunol 1990;26:107–111.
118. O'ConnorKC, ChitnisT, GriffinDE, et al. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions. J Neuroimmunol 2003;136:140–148.
119. O'ConnorKC, McLaughlinKA, De JagerPL, et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med 2007;13:211–217.
120. DaleRC, MorovatA. Interleukin-6 and oligoclonal IgG synthesis in children with acute disseminated encephalomyelitis. Neuropediatrics 2003;34:141–145.
121. IchiyamaT, ShojiH, KatoM, et al. Cerebrospinal fluid levels of cytokines and soluble tumour necrosis factor receptor in acute disseminated encephalomyelitis. Eur J Pediatr 2002;161:133–137.
122. YoshitomiT, MatsubaraT, NishikawaM, et al. Increased peripheral blood interferon gamma-producing T cells in acute disseminated encephalomyelitis. J Neuroimmunol 2000;111:224–228.
123. IshizuT, MinoharaM, IchiyamaT, et al. CSF cytokine and chemokine profiles in acute disseminated encephalomyelitis. J Neuroimmunol 2006;175:52–58.
124. OhHH, KwonSH, KimCW, et al. Molecular analysis of HLA class II-associated susceptibility to neuroinflammatory diseases in Korean children. J Korean Med Sci 2004;19:426–430.
125. McElroyJP, OksenbergJR. Multiple sclerosis genetics. Curr Top Microbiol Immunol 2008;318:45–72.
126. BoikoA, VorobeychikG, PatyD, DevonshireV, SadovnickD. Early onset multiple sclerosis: A longitudinal study. Neurology 2002;59:1006–1010.
127. SuppiejA, VittoriniR, FontaninM, et al. Acute disseminated encephalomyelitis in children: Focus on relapsing patients. Pediatr Neurol 2008;39:12–17.